Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
What do experts say
Diabetes and the COVID-19 pandemic: how insights from recent experience might guide future management
With a different concentration (e.g., 2.5 mg/mL), the same 0.5 mg dose would require 20 units
GLP-1 Market Segmentation By Type of Molecule Outlook (Revenue, USD Billion, 20212034) Biologics Small Molecules By Active Compound Used Outlook (Revenue, USD Billion, 20212034) Dulaglutide Liraglutide Orforglipron Retatrutide Semaglutide Survodutide Tirzepatide Other Active Compounds By Type of GLP-1 Agonist Drugs Outlook (Revenue, USD Billion, 20212034) Long-acting GLP-1 Agonist Short-acting GLP-1 Agonist By Route of Administration Outlook (Revenue, USD Billion, 20212034) Oral Parenteral By Target Indication Outlook (Revenue, USD Billion, 20212034) Alzheimers Disease Non-Alcoholic Steatohepatitis Obesity Sleep Apnea Type 2 Diabetes By Regional Outlook (Revenue, USD Billion, 20212034) North America U.S
US$ 20.76
US$ 29.31
US$ 25.80
US$ 27.29
